American Association for Cancer Research
10559965epi160812-sup-173061_1_supp_3760836_tt8hjh.docx (108.5 kB)

Supplemental Table 2 from Approach for Classification and Severity Grading of Long-term and Late-Onset Health Events among Childhood Cancer Survivors in the St. Jude Lifetime Cohort

Download (108.5 kB)
journal contribution
posted on 2023-03-31, 13:47 authored by Melissa M. Hudson, Matthew J. Ehrhardt, Nickhill Bhakta, Malek Baassiri, Hesham Eissa, Wassim Chemaitilly, Daniel M. Green, Daniel A. Mulrooney, Gregory T. Armstrong, Tara M. Brinkman, James L. Klosky, Kevin R. Krull, Noah D. Sabin, Carmen L. Wilson, I-Chan Huang, Johnnie K. Bass, Karen Hale, Sue Kaste, Raja B. Khan, Deo Kumar Srivastava, Yutaka Yasui, Vijaya M. Joshi, Saumini Srinivasan, Dennis Stokes, Mary Ellen Hoehn, Matthew Wilson, Kirsten K. Ness, Leslie L. Robison

Medical Event Grading in SJLIFE


St. Jude Children's Research Hospital Cancer Center

St. Jude Lifetime Cohort Study

American Lebanese Syrian Associated Charities



Characterization of toxicity associated with cancer and its treatment is essential to quantify risk, inform optimization of therapeutic approaches for newly diagnosed patients, and guide health surveillance recommendations for long-term survivors. The NCI Common Terminology Criteria for Adverse Events (CTCAE) provides a common rubric for grading severity of adverse outcomes in cancer patients that is widely used in clinical trials. The CTCAE has also been used to assess late cancer treatment-related morbidity but is not fully representative of the spectrum of events experienced by pediatric and aging adult survivors of childhood cancer. Also, CTCAE characterization does not routinely integrate detailed patient-reported and medical outcomes data available from clinically assessed cohorts. To address these deficiencies, we standardized the severity grading of long-term and late-onset health events applicable to childhood cancer survivors across their lifespan by modifying the existing CTCAE v4.03 criteria and aligning grading rubrics from other sources for chronic conditions not included or optimally addressed in the CTCAE v4.03. This article describes the methods of late toxicity assessment used in the St. Jude Lifetime Cohort Study, a clinically assessed cohort in which data from multiple diagnostic modalities and patient-reported outcomes are ascertained. Cancer Epidemiol Biomarkers Prev; 26(5); 666–74. ©2016 AACR.

Usage metrics

    Cancer Epidemiology, Biomarkers & Prevention



    Ref. manager